Clinuvel Pharmaceuticals Health Care
Biotech Healthcare North America Pharmaceuticals

$17.88 -0.10 (-0.56%)

High $18.20	Low $17.50	Trades 1,245	Turnover $1,190,837	Volume 66,664
30 June 2023 at 4:10pm

Market Cap (14-Sep) $405,440,320 (262nd)	Close (30-Jun) $17.88 0 (0%)	Volume (30-Jun) 66,664	Shortsold (8-Sep) 4,107,006 (8.14%) (26th)
52w High $13.40	52w Low $7.93	P/E 12.97	EPS 0.67

Short Interest

ASIC data, 8 Sep 2026

% Shorted

8.14% 0.01

vs 8.15% prior report

Most Shorted Rank

26th

of 694 shorted ASX stocks

Peak Short

12.24%

Dec 2025

Days to Cover

30.4

at 50d avg vol

View full short position history →

	Subject
	CUV CUV Ann: Notification regarding unquoted securities - CUV
	1 (current) 2 3
	CUV CUV Ann: Two Grounds of Appeal Upheld by NICE Panel
	CUV CUV Ann: Notification of cessation of securities - CUV
	CUV CUV Ann: Presentation - Melbourne Twilight Briefing
	CUV CUV Ann: Change of Director's Interest Notice
	CUV CUV Ann: CLINUVEL Newsletter III - June 2023
	CUV CUV Ann: Strategic Update VI
	CUV CUV Ann: PRENUMBRA administered to moderate & severe stroke patients
	CUV CUV Ann: Expansion of global porphyria programs
	CUV CUV Ann: CLINUVEL Newsletter II - April 2023
	CUV CUV Ann: Investor Presentation - NYC Nasdaq Event
	CUV CUV Ann: Technical Note - CUV803 Study and AIS
	CUV CUV Ann: First stroke patient treated with PRENUMBRA Instant
	CUV CUV Ann: DNA Repair data presented at AAD Meeting
	CUV CUV Ann: Statement on Silicon Valley Bank
	CUV CUV Ann: Proposed issue of securities - CUV
	CUV CUV Ann: Commercial Update SCENESSE
	CUV CUV Ann: Relief from Quarterly Reporting
	CUV CUV Ann: CLINUVEL launches first dermatocosmetic product
	CUV CUV Ann: Proposed issue of securities - CUV
	CUV CUV Ann: Global SCENESSE demand drives increased revenues, earnings
	CUV CUV Ann: CUV Appendix 4D Half Year Report
	CUV CUV Ann: PRENUMBRA formulation completed for clinical trial use
	CUV CUV Ann: Chair's Letter
	CUV CUV Ann: Technical note - CUV151 results
	CUV CUV Ann: Afamelanotide reduces UV skin damage in a healthy population
	CUV CUV Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CUV CUV Ann: NEURACTHEL manufacturing processes advance
	CUV CUV Ann: Technical Note - Xeroderma Pigmentosum
	CUV CUV Ann: afamelanotide Reduces DNA Photodamage in XP
	CUV CUV Ann: CLINUVEL Newsletter I - January 2023
	CUV CUV Ann: CLINUVEL Newsletter VI - December 2022
	CUV CUV Ann: Notification of cessation of securities - CUV
	CUV CUV Ann: Presentation - Jefferies London Healthcare Conference
	CUV CUV Ann: CLINUVEL Newsletter V - November 2022
	CUV CUV Ann: Change of Director's Interest Notice
	CUV CUV Ann: Quarterly Activities/Appendix 4C Cash Flow Report Re-issued
	CUV CUV Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CUV CUV Ann: Results of Meeting
	CUV CUV Ann: Chair Address
	CUV CUV Ann: Melbourne Investor Briefing Presentation
	CUV CUV Ann: First vitiligo patient enrolled in monotherapy study
	CUV CUV Ann: Investor Presentation - Sydney
	CUV CUV Ann: Notice of Annual General Meeting/Proxy Form
	CUV CUV Ann: Strategic Update V
	CUV CUV Ann: Presentation - HC Wainright Global Investment Conference
	CUV CUV Ann: Annual General Meeting Date
	CUV CUV Ann: CLINUVEL submits label expansion for adolescent EPP patients
	CUV CUV Ann: S&P DJI Announces September 2022 Quarterly Rebalance
	CUV CUV Ann: CLINUVEL Investor Webinar Financial Results 2022

Similar Companies

CSL

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
14-Sep	$8.31	120,511	+0.27 (3.36%)
11-Sep	$8.04	141,999	+0.03 (0.37%)
10-Sep	$8.01	178,094	-0.15 (1.84%)
09-Sep	$8.16	82,253	+0.09 (1.12%)
08-Sep	$8.07	112,557	-0.09 (1.10%)
07-Sep	$8.16	72,330	+0.01 (0.12%)
04-Sep	$8.15	112,579	-0.11 (1.33%)
03-Sep	$8.26	92,511	-0.05 (0.60%)
02-Sep	$8.31	187,737	+0.07 (0.85%)
01-Sep	$8.24	251,681	+0.22 (2.74%)
31-Aug	$8.02	332,582	-0.45 (5.31%)
28-Aug	$8.47	571,697	-0.71 (7.73%)
27-Aug	$9.18	479,189	-1.34 (12.74%)
26-Aug	$10.52	56,115	-0.08 (0.75%)
25-Aug	$10.60	74,465	+0.28 (2.71%)
7 up, 8 down, and 0 flat days

Clinuvel Pharmaceuticals Health Care
Biotech Healthcare North America Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

CUV Clinuvel Pharmaceuticals Health Care Biotech Healthcare North America Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Clinuvel Pharmaceuticals Health Care
Biotech Healthcare North America Pharmaceuticals